Brian Gorman – Trademark Portfolio

Entity Type: 01

Brian Gorman holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CONNORTV and IT'S DO-BE TIME. The owner is based in Hoboken, NJ.

Apt. 604

300 Grand Street

Hoboken, NJ 07030

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Brian Gorman's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

41
Education & Entertainment (2 filings)

Education; providing of training; entertainment; sporting and cultural activities

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

25
Clothing (1 filing)

Clothing, footwear, headgear

Frequently Asked Questions

How many trademarks does Brian Gorman have?

Brian Gorman has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Brian Gorman file in?

Brian Gorman files trademarks across 3 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 35 (Advertising & Business), Class 25 (Clothing). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.

What are Brian Gorman's most well-known trademarks?

Brian Gorman's registered trademark portfolio includes well-known marks such as CONNORTV and IT'S DO-BE TIME. These are among 2 currently registered trademarks in the portfolio.

What is Brian Gorman's trademark registration success rate?

Brian Gorman has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.